(19)
(11) EP 4 798 622 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24883382.4

(22) Date of filing: 25.10.2024
(51) International Patent Classification (IPC): 
C07K 16/24(2006.01)
A61K 38/04(2006.01)
A61K 39/395(2006.01)
C12N 5/10(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/241; C07K 2317/22; C07K 2317/569; C07K 2317/92; C07K 2317/76; C07K 2317/24
(86) International application number:
PCT/US2024/052920
(87) International publication number:
WO 2025/090840 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.10.2023 US 202363593885 P

(71) Applicant: Rutgers, the State University of New Jersey
New Brunswick, NJ 08901 (US)

(72) Inventors:
  • D'ADAMIO, Luciano
    New Brunswick, New Jersey 08901 (US)
  • YIN, Tao
    New Brunswick, New Jersey 08901 (US)

(74) Representative: De Clercq & Partners 
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)

   


(54) ANTIGEN BINDING MOLECULES TARGETING TNF-ALPHA